Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Malignant gliomas.

Patrick Y Wen¹, Santosh Kesari

¹Center for Neuro-Oncology, Dana Farber Cancer Institute, SW430D, 44 Binney Street, Boston, MA 02115, USA. pwen@partners.org

Current Neurology and Neuroscience Reports

|April 23, 2004

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Correcting the drug development paradigm for glioblastoma requires serial tissue sampling.

Nature medicine·2023

Same author

Insulin feedback is a targetable resistance mechanism of PI3K inhibition in glioblastoma.

Neuro-oncology·2023

Same author

Author Correction: Vorasidenib and ivosidenib in IDH1-mutant low-grade glioma: a randomized, perioperative phase 1 trial.

Nature medicine·2023

Same author

Bavituximab Decreases Immunosuppressive Myeloid-Derived Suppressor Cells in Newly Diagnosed Glioblastoma Patients.

Clinical cancer research : an official journal of the American Association for Cancer Research·2023

Same author

Understanding the patient experience and treatment benefits in patients with non-small-cell lung cancer with brain metastasis.

Cancer medicine·2023

Same author

Vorasidenib in IDH1- or IDH2-Mutant Low-Grade Glioma.

The New England journal of medicine·2023

Same journal

The Noradrenergic Brain in Parkinson's Disease.

Current neurology and neuroscience reports·2026

Same journal

Mapping the Silent Onset of Parkinson's Disease: Monoamine Imaging in the Era of the Race for Preclinical Intervention.

Current neurology and neuroscience reports·2026

Same journal

Functional and Structural Brain Imaging Correlates of Treatment Response in Functional Movement Disorder.

Current neurology and neuroscience reports·2026

Same journal

Astrocytopathy in Wernicke Encephalopathy and Neuromyelitis Optica Spectrum Disorder. Pathogenic Differences With Occasional Clinical and Neuroimaging Overlap. A Review.

Current neurology and neuroscience reports·2026

Same journal

When is the Radiologically Isolated Syndrome already Multiple Sclerosis According to the 2024 McDonald Criteria?

Current neurology and neuroscience reports·2026

Same journal

Assessment and Management of Post-traumatic Headache.

Current neurology and neuroscience reports·2026

See all related articles

Malignant gliomas, common brain tumors, have limited treatment options. Recent advances focus on targeted molecular therapies, offering new hope for patients.

Area of Science:

Neuro-oncology
Molecular biology
Cancer therapy

Background:

Malignant gliomas represent the most frequent primary brain tumors.
Current therapeutic strategies for malignant gliomas exhibit limitations.
Recent scientific progress has been made in understanding and treating these tumors.

Purpose of the Study:

To review recent advances in the therapy of malignant gliomas.
To highlight the role and progress of targeted molecular therapies.

Main Methods:

Literature review of recent studies on malignant glioma treatment.
Focus on targeted molecular therapies and their clinical implications.

Main Results:

Discussion of emerging therapeutic strategies for malignant gliomas.

Related Experiment Videos

Emphasis on advancements in targeted molecular therapies.

Conclusions:

Targeted molecular therapies represent a promising frontier in malignant glioma treatment.
Continued research is crucial for improving patient outcomes in neuro-oncology.